Phosphatase Inhibitor Cocktail II (100× DMSO) Options
Use of potent CYP1A2 inhibitors need to be discontinued prior to initiating pirfenidone and averted for the duration of therapy; if robust CYP1A2 inhibitors are the only real drug of preference, dosage reductions are proposedThe majority of the individuals enrolled in a single review on PFD and its effect on respiratory-connected hospitalization ha